MSAID
Martin Frejno began their work experience as a Werkstudent at Bayer Crop Science in 2008. Martin then worked as a Student Teaching Assistant at Universität zu Köln from 2008 to 2009. In 2011, they worked as a Student Intern at Bayer Pharmaceuticals. From 2012 to 2012, Martin served as a Graduate Student Research Assistant at Rheinische Friedrich-Wilhelms-Universität Bonn. Martin then joined Technische Universität München in 2016 as a Bioinformatician until 2019. In 2019, Martin became the Co-Founder and Chief Executive Officer of MSAID.
Martin Frejno completed their Abitur degree at Norbert Gymnasium Knechtsteden from 1997 to 2006. Martin then pursued a Bachelor of Science degree in Biologie, allgemein at the University of Cologne from 2007 to 2010. Following this, they furthered their education at The University of Bonn, where they obtained a Master of Science degree in Life and Medical Sciences from 2010 to 2012. Finally, Martin completed their highest level of education at the University of Oxford, earning a DPhil (PhD) degree in Oncology from 2012 to 2016.
This person is not in any teams
MSAID
MSAID transforms the way scientists analyze proteomics data. MSAID is a bioinformatics spin-off from the Technical University of Munich, Germany and is located at the high-tech-center gate, which is part of the TUM campus in Garching. The company was founded by an interdisciplinary team of scientists with the vision to provide better computational solutions to the field of proteomics. The team has an exceptionally strong track record and long-standing expertise in the acquisition, analysis, and interpretation of proteomic data. Our ambition is to replace current algorithms for proteomics with powerful, AI-based solutions, thereby paving the way for a smarter, deeper, and more reliable way of interrogating proteomic data.